Vicki Moore, PhD

Contributing Writer https://www.thecardiologyadvisor.com

Vicki Moore, PhD, is a freelance medical writer for Hematology Advisor. Vicki received her PhD in biology from Arizona State University, where her research emphasized molecular biology, biochemistry, and metabolic engineering. She also has experience with predictive analytics and is intrigued by its applications to medicine. Vicki has been a medical writer, focusing on areas of hematology and oncology, among other specialties, since late 2017. You can find her on Linkedin at linkedin.com/in/vicki-moore-93950913

All articles by Vicki Moore, PhD

Hematology Advisor spoke with experts about the new ASH clinical practice guidelines for VTE.

Vascular Medicine

Risk Factors for Venous Thromboembolism in Adolescent Girls Receiving Hormonal Therapy

By

Vicki Moore, PhD

May 13, 2021

Researchers sought to identify and analyze risk factors for thrombosis in adolescent girls receiving hormonal therapy.

Vascular Medicine

von Willebrand Factor Plasma Levels May Affect Future Venous Thromboembolism Risk

By

Vicki Moore, PhD

January 28, 2021

A population-based analysis suggested that plasma levels of von Willebrand factor may be a potential biomarker for the future risk of incident venous thromboembolism.

Interior view of blood vessel

Vascular Medicine

Thromboelastography for Patients With Slow-Flow Vascular Abnormalities

By

Vicki Moore, PhD

December 11, 2020

In minor procedures, coagulation differences may not be clinically significant to determine bleeding or thrombotic periprocedure complication risks.

Vascular Medicine

Venous Thromboembolism Risk With Orthopedic Surgery in Thrombophilia

By

Vicki Moore, PhD

December 11, 2020

Patients with thrombophilia demonstrate an elevated risk for venous thromboembolism after undergoing orthopedic surgery.

Vascular Medicine

Serum Antiphospholipid, Phospholipid-Binding Protein Antibodies in COVID-19

By

Vicki Moore, PhD

November 30, 2020

Prothrombotic autoantibodies, similar to those with antiphospholipid syndrome, appear to be elevated in hospitalized patients with COVID-19.

Pulmonary Vasculature

Prevalence of Pulmonary Hypertension in Patients With Myeloproliferative Neoplasms

By

Vicki Moore, PhD

November 20, 2020

A new meta-analysis indicates that the true prevalence of pulmonary hypertension linked to myeloproliferative neoplasms is not well understood.

Vascular Medicine

Venous Thromboembolism Rates in Patients With SARS-CoV-2 Infection

By

Vicki Moore, PhD

November 23, 2020

In a new study, researchers reported on the frequency of VTE among more than 6000 patients who tested positive for infection with SARS-CoV-2.

Doctor Showing Digital Tablet To Patient in ICU

Vascular Medicine

Venous Thromboembolism Events With COVID-19 in an Intensive Care Unit

By

Vicki Moore, PhD

August 7, 2020

COVID-19 ICU patients exhibited distinct phenotypic traits that suggested standard VTE prophylaxis is insufficient in this population.

Vascular Medicine

Model for Predicting Refractory Immune-Mediated Thrombotic Thrombocytopenic Purpura

By

Vicki Moore, PhD

June 22, 2020

Investigators developed an accurate prediction model for the early identification of refractory immune-mediated TTP.

cardiac ultrasound echo deep venous thrombosis

Vascular Medicine

Risk of Thrombosis With Treatments for Newly Diagnosed Multiple Myeloma

By

Vicki Moore, PhD

June 18, 2020

Despite thromboprophylaxis, patients who have newly developed multiple myeloma are at an “unacceptably high VTE risk”, study results suggest.

Next post in Vascular Medicine

Model May Improve Decision Making for Ascending Aortic Aneurysms